Ultra Clean Holdings, Inc.
UCTT
$77.50
-10.89%
Ultra Clean Holdings, Inc. manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry, including precision robotic solutions and gas delivery systems. As a key supplier to leading semiconductor equipment makers, it holds a distinct position as a critical enabler of advanced chip manufacturing. The stock is currently attracting attention due to its dramatic price surge over the past year, driven by strong demand for semiconductor capital equipment and the company's expanding role in the AI and advanced packaging ecosystem. However, recent volatility and a pullback from highs have sparked debate about valuation sustainability and near-term growth momentum.…
UCTT
Ultra Clean Holdings, Inc.
$77.50
Investment Opinion: Should I buy UCTT Today?
Rating: Hold. The thesis is that UCTT offers a speculative opportunity with significant upside if revenue growth accelerates, but current financials and decelerating trends warrant caution. The analyst consensus is Buy with an average target of $113.40, but the stock's recent pullback and negative earnings suggest waiting for a better entry point or confirmation of growth.
Supporting Evidence: The trailing P/S of 0.57x is below the industry average of 1-3x, but the negative net margin of -3.35% and negative free cash flow of -$44M TTM indicate the company is not yet profitable. Revenue growth of 2.91% YoY is modest, and the forward revenue estimate of $4.553B implies a 122% jump, which is highly optimistic. The P/B of 1.66x is near historical lows, suggesting the market is pricing in low returns. The implied upside to the average analyst target is 22.3%, but the wide range ($92-$130) reflects uncertainty.
Risks & Conditions: The Hold rating would upgrade to Buy if the company reports accelerating revenue growth above 10% YoY and positive free cash flow, or if the stock pulls back to the $70-$80 range, offering a better risk/reward. It would downgrade to Sell if revenue growth turns negative or if the company announces a dilutive equity offering. The stock appears fairly valued relative to its current earnings power but undervalued relative to growth expectations, making it a speculative hold.
Sign up to view all
UCTT 12-Month Price Forecast
The outlook for UCTT is balanced between the potential for a growth reacceleration and the reality of current financial weakness. The base case of modest growth and gradual margin improvement is most likely, with the stock trading near the average analyst target. The bull case requires a dramatic revenue surge that seems aggressive given recent trends, while the bear case could materialize if the semiconductor cycle turns. The neutral stance reflects the high uncertainty and wide range of outcomes. An upgrade to bullish would require evidence of accelerating revenue growth and positive free cash flow; a downgrade to bearish would follow a sustained decline in orders or a liquidity event.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ultra Clean Holdings, Inc.'s 12-month outlook, with a consensus price target around $116.40 and implied upside of +50.2% versus the current price.
Average Target
$116.40
0 analysts
Implied Upside
+50.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$92 - $145
Analyst target range
Five analysts cover UCTT, with a consensus recommendation leaning bullish (all recent ratings are Buy/Outperform). The average target price is $113.40, implying approximately +22.3% upside from the current price of $92.75. The distribution shows no Hold or Sell ratings, indicating strong bullish sentiment among covering analysts. The target range spans from a low of $92.00 to a high of $130.00. The low target is essentially at the current price, suggesting downside risk is limited if the company meets expectations, while the high target implies +40.2% upside, likely assuming multiple expansion or accelerating growth. The spread of $38 (41% of the average target) indicates moderate uncertainty. Recent ratings from TD Cowen, Needham, and Oppenheimer have all been reiterated as Buy/Outperform, with no downgrades, signaling consistent confidence. The absence of negative revisions and the unanimous bullish stance suggest analysts see the recent pullback as a buying opportunity, though the wide range implies that outcomes are highly dependent on execution and market conditions.
Bulls vs Bears: UCTT Investment Factors
Ultra Clean Holdings presents a high-risk, high-reward opportunity. On the bull side, the company benefits from strong secular demand in semiconductor capital equipment, a unanimous analyst Buy consensus with 22% upside, and improving margins from deeply negative levels. The trailing P/S of 0.57x appears cheap relative to growth expectations. However, the bear case is equally compelling: the company is unprofitable with negative free cash flow, revenue growth is decelerating, and the stock has experienced a sharp pullback from its highs. The single most important tension is whether the company can deliver the explosive revenue growth implied by forward estimates (122% increase) to justify its current valuation and return to profitability. If growth reaccelerates, the stock could re-rate significantly; if not, the stock may test its 52-week low of $21.28. Currently, the bearish evidence from recent financials is stronger, but the bullish case rests on future execution.
Bullish
- Strong Revenue Growth Trajectory: Revenue grew from $518.6M in Q1 2025 to $533.7M in Q1 2026, a 2.91% YoY increase, and the forward revenue estimate of $4.553B implies a 122% jump from TTM revenue of ~$2.05B, reflecting market expectations of explosive growth driven by semiconductor capital equipment demand.
- Analyst Consensus Bullish with 22% Upside: All five analysts rate the stock Buy/Outperform with an average target of $113.40, implying 22.3% upside from $92.75. The low target of $92.00 is essentially at the current price, suggesting limited downside risk if fundamentals hold.
- Improving Profitability Trajectory: Net margin improved from -31.2% in Q2 2025 (due to a large impairment) to -3.35% in Q1 2026, and operating margin turned positive at 2.14% in Q1 2026 versus -27.3% in Q2 2025, indicating the company is on a path to profitability.
- Low Valuation Relative to Growth Potential: Trailing P/S of 0.57x is well below the industry average of 1-3x, and forward P/S of 0.26x based on estimated revenue of $4.553B suggests deep value if growth materializes. P/B of 1.66x is near the low end of its 5-year range (1.1x-4.2x), offering a margin of safety.
Bearish
- Negative Earnings and Cash Flow: The company reported a net loss of -$17.9M in Q1 2026 and TTM net income of -$44M, with negative free cash flow of -$42.9M in Q1 2026 and -$44M TTM. This lack of profitability and cash generation raises sustainability concerns.
- High Debt and Financial Leverage: Debt-to-equity ratio of 1.14 indicates moderate leverage, but the company repaid $122.7M in debt in Q1 2026, straining cash flow. Interest expense of $7.3M in Q1 2026 consumes a significant portion of operating income ($11.4M), leaving little room for error.
- Decelerating Revenue Growth: Revenue growth decelerated from 9.2% YoY in Q4 2024 to 2.91% in Q1 2026, and sequential revenue declined from $563.3M in Q4 2024 to $533.7M in Q1 2026. This trend contradicts the market's expectation of a massive revenue surge.
- Extreme Volatility and Recent Pullback: With a beta of 1.834, the stock is 83.4% more volatile than the market. It has pulled back -14.45% in the past month and -36.33% from its 52-week high of $144.22, indicating high downside risk and potential for further correction.
UCTT Technical Analysis
The stock is in a powerful long-term uptrend, with a 1-year price change of +291.35%, massively outperforming the S&P 500's +16.47%. Currently trading at $92.75, it sits at 64.3% of its 52-week range ($21.28 to $144.22), indicating it has pulled back from the highs but remains well above the midpoint. This positioning suggests the stock is in a corrective phase within a secular uptrend, offering a potential entry point for momentum investors if support holds. Short-term momentum has decelerated sharply, with a 1-month price change of -14.45% contrasting with a 3-month change of +11.73%. This divergence from the 1-year trend signals a significant pullback, possibly a mean-reversion move after an overextended rally. The relative strength versus the S&P 500 over 1 month is -15.23%, confirming underperformance, while the 3-month relative strength remains positive at +8.23%, suggesting the correction may be temporary. The 52-week high of $144.22 represents key resistance, while the 52-week low of $21.28 is deep support. A breakout above $144.22 would signal a resumption of the uptrend, while a breakdown below the recent low near $90 could test lower supports. With a beta of 1.834, the stock is 83.4% more volatile than the market, amplifying both upside and downside moves, which is critical for risk management.
Beta
1.83
1.83x market volatility
Max Drawdown
-45.6%
Largest decline past year
52-Week Range
$21-$144
Price range past year
Annual Return
+213.4%
Cumulative gain past year
| Period | UCTT Return | S&P 500 |
|---|---|---|
| 1m | -34.8% | +1.6% |
| 3m | +7.6% | +4.1% |
| 6m | +63.2% | +6.8% |
| 1y | +213.4% | +16.3% |
| ytd | +183.7% | +8.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
UCTT Fundamental Analysis
Revenue has been growing modestly, with Q1 2026 revenue of $533.7 million, up 2.91% year-over-year from $518.6 million in Q1 2025. However, the multi-quarter trend shows deceleration from Q4 2024's $563.3 million (which had 9.2% YoY growth based on prior data). The Products segment generated $465.7 million (87.3% of revenue) and Services $68 million (12.7%), indicating product sales are the primary driver. The growth trajectory is positive but slowing, which may temper expectations for rapid expansion. The company is currently unprofitable, with a net loss of -$17.9 million in Q1 2026 and a trailing twelve-month net income of -$44 million (based on quarterly data). Gross margin was 15.81%, relatively stable around 15-17% over recent quarters, but operating margin was only 2.14%, reflecting high operating expenses. The net margin of -3.35% shows losses are narrowing from -31.2% in Q2 2025 (which included a large impairment), indicating improving profitability trajectory. The balance sheet shows a debt-to-equity ratio of 1.14 and a current ratio of 3.19, indicating adequate liquidity but moderate leverage. Free cash flow was negative -$42.9 million in Q1 2026, and trailing twelve-month FCF is -$44 million, suggesting the company is not yet self-funding. However, cash from operations was -$33.3 million, and capital expenditures were modest at $9.6 million. The negative FCF yield and reliance on external financing (debt repayment of $122.7 million in Q1) highlight financial risk, though the current ratio above 3 provides a cushion.
Quarterly Revenue
$533700000.0B
2026-03
Revenue YoY Growth
+2.9%
YoY Comparison
Gross Margin
15.8%
Latest Quarter
Free Cash Flow
$-44000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is UCTT Overvalued?
Since net income is negative (TTM net income of -$44 million), the trailing P/E is not meaningful, so we lead with the price-to-sales (P/S) ratio. The trailing P/S is 0.57x based on current price and TTM revenue of approximately $2.05 billion (sum of last four quarters). The forward P/S is not directly provided but can be estimated using estimated revenue of $4.553 billion for the next fiscal year, implying a forward P/S of about 0.26x. The large gap between trailing and forward P/S reflects the market's expectation of significant revenue growth, which is optimistic. Compared to the industry average (not provided, but typically semiconductor equipment suppliers trade at 1-3x sales), UCTT's trailing P/S of 0.57x appears low, suggesting a discount. However, given the company's negative margins and high debt, the discount may be justified. The P/B ratio of 1.66x is below the historical average (e.g., 4.25x in Q1 2026), indicating the stock is trading at a discount to book value relative to its own history. The current P/B is near the lower end of its 5-year range (which has fluctuated from ~1.1x to ~4.2x), suggesting the market is pricing in lower returns on equity or higher risk. This could represent a value opportunity if the company returns to profitability, but it also reflects the recent earnings deterioration.
PE
-6.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-53.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The company's negative net income of -$17.9M in Q1 2026 and TTM net loss of -$44M highlight persistent unprofitability. Free cash flow is deeply negative at -$42.9M in Q1 2026, forcing reliance on debt or equity financing. The debt-to-equity ratio of 1.14 is manageable but interest expense of $7.3M consumes 64% of operating income ($11.4M), leaving minimal cushion. Revenue concentration in the Products segment (87.3% of revenue) exposes the company to cyclical swings in semiconductor capital spending. The negative P/E of -6.51x underscores that earnings are not supporting the stock price.
Market & Competitive Risks: The stock's beta of 1.834 implies high sensitivity to market downturns, with a 1-month relative strength of -15.23% versus the S&P 500 confirming recent underperformance. The trailing P/S of 0.57x, while low, may be a value trap if revenue growth disappoints. The forward P/S of 0.26x implies the market is pricing in massive growth, leaving little room for error. Competitive pressures from larger suppliers and potential customer concentration (semiconductor equipment makers) could compress margins. The absence of recent news provides no catalyst for sentiment improvement.
Worst-Case Scenario: A sustained downturn in semiconductor capital spending, coupled with failure to achieve the projected revenue growth, could lead to further margin compression and cash burn. If the company misses earnings estimates and analysts downgrade, the stock could retest its 52-week low of $21.28, representing a -77.1% decline from the current price of $92.75. The historical max drawdown of -36.33% from the 52-week high of $144.22 has already occurred, but further downside to $21.28 would mean a total loss of 85% from the peak.
FAQ
The key risks are: 1) Financial risk: negative net income of -$17.9M in Q1 2026 and negative free cash flow of -$42.9M, with debt-to-equity of 1.14. 2) Execution risk: revenue growth decelerating to 2.91% YoY, far below the forward estimate of 122% growth. 3) Macro risk: beta of 1.834 makes the stock highly sensitive to market downturns, and a semiconductor cycle downturn could severely impact demand. 4) Valuation risk: the stock has already pulled back 36% from its 52-week high, and further downside to $21.28 is possible. The most severe risk is a liquidity crisis if cash burn continues and debt markets tighten.
The 12-month forecast is mixed. The bull case (25% probability) sees the stock reaching $130-$150, driven by AI-driven demand and profitability. The base case (50% probability) targets $100-$120, with modest growth and gradual margin improvement. The bear case (25% probability) sees the stock falling to $50-$92, or even lower, if the semiconductor cycle turns or execution falters. The most likely scenario is the base case, with the stock trading near the average analyst target of $113.40, assuming stable demand and no major shocks. The wide range reflects high uncertainty.
UCTT appears undervalued on a price-to-sales basis, with a trailing P/S of 0.57x versus the industry average of 1-3x. However, the negative P/E of -6.51x indicates the company is not profitable, so traditional valuation metrics are distorted. The forward P/S of 0.26x based on estimated revenue of $4.553B suggests deep value if that growth materializes, but the implied 122% revenue jump is highly optimistic. The P/B of 1.66x is near the low end of its 5-year range (1.1x-4.2x), suggesting the market is pricing in low returns on equity. Overall, the stock is undervalued relative to growth expectations but fairly valued relative to current earnings.
UCTT is a speculative buy for investors with a high risk tolerance. The stock offers 22.3% upside to the average analyst target of $113.40, but the company is currently unprofitable with negative free cash flow of -$44M TTM. The trailing P/S of 0.57x is low, but this reflects the lack of earnings. The biggest downside risk is a further pullback to the 52-week low of $21.28, representing a 77% decline. For long-term investors willing to tolerate volatility, it could be a good buy if revenue growth reaccelerates; for conservative investors, it is best avoided until profitability improves.
UCTT is more suitable for long-term investment given its high volatility (beta 1.834) and speculative nature. Short-term trading is risky due to the recent -14.45% monthly decline and -36.33% drawdown from the high. The company's negative earnings and cash flow mean it needs time to execute its growth strategy. A minimum holding period of 3-5 years is recommended to ride out the semiconductor cycle. The stock pays no dividend, so total return depends entirely on price appreciation. For short-term traders, the high volatility offers opportunities but also significant risk of loss.